RENAULT INH. EO 3,81/ FR0000131906 /
16.05.2024 8:00:56 | Изменение +0.030 | Объем сделки | Бид11:56:43 | Предложение11:56:43 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
50.000EUR | +0.06% | 0 Оборот: 0.000 |
49.610Величина цены спроса: 202 | 49.640Величина цены предложения: 202 | 13.45 млрдEUR | 2.39% | 6.12 |
GlobeNewswire
12:00
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...
GlobeNewswire
12:00
Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire
12:00
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainl...
GlobeNewswire
12:00
LANZATECH ALERT: Bragar Eagel & Squire, P.C. Investigates De-SPAC Merger of LNZA and AMCI and Encour...
GlobeNewswire
12:00
SHIMMICK ALERT: Bragar Eagel & Squire, P.C. is Investigating Shimmick Corporation on Behalf of Shimm...
GlobeNewswire
12:00
INOTIV ALERT: Bragar Eagel & Squire, P.C. is Investigating Inotiv, Inc. on Behalf of Inotiv Stockhol...
GlobeNewswire
12:00
FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. is Investigating FutureFuel Corp. on Behalf of FutureF...
GlobeNewswire
12:00
South Rampart Pharma Publishes SRP-001's Unique Pain Relief Mechanism and Phase 1 Trial Results in S...
GlobeNewswire
12:00
More Viewers are Trading Down to Ad-supported TV, Propelling Growth for SVOD Ad-tiers and FAST Platf...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница